Search hospitals > New Jersey > Neptune
Jersey Shore University Medical Center
Claim this profileNeptune, New Jersey 07753
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
Conducts research for Ovarian Cancer
184 reported clinical trials
18 medical researchers
Summary
Jersey Shore University Medical Center is a medical facility located in Neptune, New Jersey. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Ovarian Cancer and other specialties. Jersey Shore University Medical Center is involved with conducting 184 clinical trials across 386 conditions. There are 18 research doctors associated with this hospital, such as Burton E. Appel, Andrew L. Pecora, Thomas L. Bauer, and Carlos Eduardo Silva Correia.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage I
Stage III
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Burton E. AppelHackensack University Medical Center5 years of reported clinical research
Studies Lymphoma
Studies T-Lymphoblastic Leukemia/Lymphoma
23 reported clinical trials
60 drugs studied
Andrew L. PecoraHackensack University Medical Center1 year of reported clinical research
Studies Skin Cancer
Studies Melanoma
11 reported clinical trials
14 drugs studied
Thomas L. BauerRiverview Medical Center/Booker Cancer Center10 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
16 drugs studied
Carlos Eduardo Silva CorreiaJersey Shore Medical Center3 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
7 reported clinical trials
18 drugs studied
Clinical Trials running at Jersey Shore University Medical Center
Lung Cancer
Skin Cancer
Cutaneous Melanoma
Testicular cancer
Heart Failure
Stroke
Uterine Cancer
Brain Tumor
Non-Small Cell Lung Cancer
Uterine Tumors
Serplulimab + Chemotherapy
for Small Cell Lung Cancer
This trial is testing two different treatment combinations for patients with extensive-stage small cell lung cancer who have not received any prior treatment. One group will receive a new drug called Serplulimab along with standard chemotherapy, while the other group will receive an existing drug called Atezolizumab with the same chemotherapy. Both immunotherapy drugs aim to help the immune system fight cancer, and the chemotherapy drugs work by killing cancer cells. Atezolizumab has been shown to improve survival in small-cell lung cancer when combined with chemotherapy, changing the standard first-line therapy.
Recruiting3 awards Phase 32 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Lung Screening
for Lung Cancer
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.
Recruiting1 award N/A2 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Jersey Shore University Medical Center?
Jersey Shore University Medical Center is a medical facility located in Neptune, New Jersey. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Ovarian Cancer and other specialties. Jersey Shore University Medical Center is involved with conducting 184 clinical trials across 386 conditions. There are 18 research doctors associated with this hospital, such as Burton E. Appel, Andrew L. Pecora, Thomas L. Bauer, and Carlos Eduardo Silva Correia.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.